Alnylam Pharmaceuticals, Inc. products
GIVLAARI - Prescription Medicine to Treat Acute Hepatic Porphyria (AHP)
GIVLAARI® (givosiran) is a prescription medicine used to treat acute hepatic porphyria (AHP) in adults.
OXLUMO lumasiran - Prescription Medication for the Treatment of Primary Hyperoxaluria Type 1 (PH1)
The first and only FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1). OXLUMO is a prescription medicine for the treatment of PH1 to lower oxalate in urine in children and adults.
ONPATTRO - Prescription Medicine for Adults
ONPATTRO is a prescription medicine for adults that treats the polyneuropathy caused by an illness called hereditary ATTR (hATTR) amyloidosis.
Prescription Medicine
AMVUTTRA™ (vutrisiran) is a prescription medicine given once every 3 months by a healthcare professional to treat the polyneuropathy caused by an illness called hereditary ATTR (hATTR) amyloidosis in adults. In an 18-month clinical study, AMVUTTRA-treated patients showed significant improvement in nerve function and quality of life at 9 months and continued to improve throughout the study, compared with those who received placebo.